Clinical studies have shown that Semaglutide GLP-1 can lead to significant weight loss in people who are overweight or obese, even without diabetes
Beyond these immediate metabolic effects, GLP-1 also influences lipid metabolism, inflammation, and cardiovascular health, contributing to overall metabolic stability
In May, Roche said its injection, CT-388, helped patients with obesity lose 18.8% more weight compared to those who received a placebo after 24 weeks in the phase one trial
Studies are still happening to understand why. The data from Dandelion Health showed that the 10% of people with the best response to GLP-1s had results that mirrored what clinical trials found, but the 10% with the least success with the treatments had no weight change, or even an increase in weight, over time
Heres how to store Rybelsus and the Wegovy pill, according to the each drugs prescribing information : The ideal storage temperature for oral semaglutide is 68F77F (20C25C)
This simply isnt possible without specialized technology
